Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports
Rank Ordered Listing of Organizations Receiving
5
or More Utility Patents During the Period
Having Primary Classification In
Class 530, Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof
( technology class is determined by the primary classification assigned to the patent- see 'Explanation of Data' )
( patent ownership is determined by the first-named assignee listed on a patent )
First-Named Assignee | 2011 | 2012 | 2013 | 2014 | 2015 | Total |
---|---|---|---|---|---|---|
~INDIVIDUALLY OWNED PATENT | 27 | 27 | 22 | 18 | 18 | 112 |
GENENTECH, INC. | 18 | 11 | 20 | 17 | 10 | 76 |
UNIVERSITY OF CALIFORNIA, THE REGENTS OF | 6 | 12 | 13 | 11 | 17 | 59 |
AMGEN, INC. | 16 | 12 | 9 | 10 | 6 | 53 |
BAXTER INTERNATIONAL INC. | 14 | 3 | 5 | 10 | 4 | 36 |
UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH & HUMAN SERVICES | 12 | 2 | 8 | 8 | 3 | 33 |
NOVO NORDISK A/S | 4 | 5 | 4 | 10 | 9 | 32 |
WISCONSIN ALUMNI RESEARCH FOUNDATION | 3 | 3 | 7 | 10 | 6 | 29 |
XENCOR, INC. | 4 | 10 | 6 | 7 | 2 | 29 |
ABBVIE INC. | 0 | 0 | 3 | 15 | 10 | 28 |
CHUGAI SEIYAKU KABUSHIKI KAISHA | 9 | 4 | 5 | 5 | 5 | 28 |
HOFFMANN-LA ROCHE INC. | 4 | 6 | 4 | 11 | 3 | 28 |
NOVARTIS AG (FORMERLY SANDOZ LTD.) | 5 | 9 | 4 | 4 | 5 | 27 |
ZYMOGENETICS, INC. | 6 | 7 | 6 | 4 | 1 | 24 |
AMBRX, INC. | 5 | 7 | 3 | 5 | 2 | 22 |
STANFORD UNIVERSITY | 5 | 5 | 4 | 5 | 3 | 22 |
BRISTOL-MYERS SQUIBB COMPANY | 5 | 4 | 2 | 3 | 7 | 21 |
IMMUNOMEDICS INC. | 5 | 2 | 3 | 5 | 6 | 21 |
KYOWA HAKKO KIRIN CO., LTD. | 7 | 5 | 6 | 2 | 1 | 21 |
SCHERING CORP. | 15 | 6 | 0 | 0 | 0 | 21 |
AGENSYS, INC. | 11 | 3 | 4 | 1 | 1 | 20 |
E. I. DU PONT DE NEMOURS AND COMPANY | 10 | 2 | 5 | 3 | 0 | 20 |
MERCK SHARP & DOHME CORP. | 2 | 3 | 7 | 6 | 2 | 20 |
UNIVERSITY OF TEXAS | 5 | 4 | 2 | 6 | 3 | 20 |
MEDAREX, INC. | 4 | 7 | 6 | 0 | 0 | 17 |
NEKTAR THERAPEUTICS | 2 | 5 | 6 | 1 | 3 | 17 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS | 4 | 2 | 4 | 2 | 4 | 16 |
BIOGEN IDEC MA INC. | 9 | 2 | 1 | 3 | 0 | 15 |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 3 | 1 | 4 | 4 | 3 | 15 |
ABBOTT LABORATORIES | 5 | 5 | 2 | 1 | 0 | 13 |
BIO-RAD LABORATORIES, INC. | 3 | 3 | 1 | 3 | 3 | 13 |
GE HEALTHCARE BIO-SCIENCES AB | 0 | 3 | 1 | 4 | 5 | 13 |
HUMAN GENOME SCIENCES, INC. | 6 | 5 | 2 | 0 | 0 | 13 |
IMMUNOGEN INC. | 3 | 3 | 2 | 3 | 2 | 13 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE | 0 | 2 | 6 | 3 | 2 | 13 |
NOVO NORDISK HEALTH CARE AG | 2 | 1 | 3 | 5 | 2 | 13 |
ONCOTHERAPY SCIENCE, INCORPORATED | 3 | 0 | 5 | 5 | 0 | 13 |
UNIVERSITY OF PENNSYLVANIA | 4 | 1 | 1 | 3 | 4 | 13 |
DANISCO US INC | 3 | 2 | 2 | 4 | 1 | 12 |
EMD MILLIPORE CORPORATION | 0 | 3 | 4 | 2 | 3 | 12 |
RAMOT AT TEL AVIV UNIVERSITY LTD. | 2 | 5 | 4 | 0 | 1 | 12 |
TUFTS UNIVERSITY | 3 | 1 | 4 | 3 | 1 | 12 |
WYETH | 5 | 2 | 2 | 1 | 2 | 12 |
YEDA RESEARCH AND DEVELOPMENT CO., LTD. | 3 | 2 | 5 | 1 | 1 | 12 |
ELI LILLY AND COMPANY | 4 | 5 | 1 | 1 | 0 | 11 |
MACROGENICS, INC. | 2 | 3 | 2 | 2 | 2 | 11 |
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 3 | 1 | 3 | 2 | 2 | 11 |
MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG | 3 | 2 | 1 | 5 | 0 | 11 |
SCRIPPS RESEARCH INSTITUTE | 4 | 4 | 1 | 2 | 0 | 11 |
UNITED STATES OF AMERICA, DEPARTMENT OF AGRICULTURE | 4 | 2 | 2 | 2 | 1 | 11 |
UNIVERSITY OF ILLINOIS | 3 | 2 | 3 | 2 | 1 | 11 |
ABLYNX N.V. | 0 | 2 | 1 | 3 | 4 | 10 |
ALLERGAN, INC. | 5 | 3 | 1 | 1 | 0 | 10 |
DANA-FARBER CANCER INSTITUTE, INC. | 2 | 2 | 1 | 1 | 4 | 10 |
GLAXO GROUP LIMITED | 1 | 3 | 1 | 3 | 2 | 10 |
IMMATICS BIOTECHNOLOGIES GMBH | 4 | 4 | 2 | 0 | 0 | 10 |
IMMUNEX CORPORATION | 6 | 1 | 2 | 1 | 0 | 10 |
INTREXON CORPORATION | 2 | 2 | 1 | 3 | 2 | 10 |
JAPAN SCIENCE AND TECHNOLOGY AGENCY | 5 | 0 | 2 | 2 | 1 | 10 |
PIONEER HI-BRED INTERNATIONAL, INC. | 5 | 1 | 3 | 1 | 0 | 10 |
SENOMYX, INC. | 6 | 2 | 2 | 0 | 0 | 10 |
ACADEMIA SINICA | 0 | 3 | 3 | 2 | 1 | 9 |
AILERON THERAPEUTICS, INC. | 3 | 0 | 1 | 1 | 4 | 9 |
AJINOMOTO COMPANY INCORPORATED | 0 | 0 | 2 | 3 | 4 | 9 |
DYAX CORP. | 3 | 2 | 0 | 2 | 2 | 9 |
JANSSEN BIOTECH, INC. | 0 | 0 | 3 | 3 | 3 | 9 |
JOHNS HOPKINS UNIVERSITY | 3 | 3 | 1 | 2 | 0 | 9 |
LUDWIG INSTITUTE FOR CANCER RESEARCH | 7 | 2 | 0 | 0 | 0 | 9 |
REGENERON PHARMACEUTICALS, INC. | 2 | 1 | 1 | 2 | 3 | 9 |
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE | 5 | 3 | 1 | 0 | 0 | 9 |
UCB PHARMA S.A. | 3 | 1 | 3 | 2 | 0 | 9 |
UNIVERSITY OF MINNESOTA, THE REGENTS OF | 2 | 2 | 3 | 1 | 1 | 9 |
CELL SIGNALING TECHNOLOGY, INC. | 6 | 0 | 1 | 0 | 1 | 8 |
GENERAL HOSPITAL CORPORATION | 2 | 1 | 1 | 2 | 2 | 8 |
HELIAE DEVELOPMENT, LLC | 0 | 0 | 5 | 3 | 0 | 8 |
IMMUNOCORE LIMITED | 2 | 3 | 3 | 0 | 0 | 8 |
INVENTION SCIENCE FUND I, LLC | 6 | 0 | 0 | 1 | 1 | 8 |
JNC CORPORATION | 0 | 0 | 1 | 5 | 2 | 8 |
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES | 1 | 0 | 1 | 2 | 4 | 8 |
LIFE TECHNOLOGIES CORPORATION | 1 | 0 | 5 | 1 | 1 | 8 |
MEDIMMUNE LIMITED | 3 | 1 | 2 | 1 | 1 | 8 |
MEDIMMUNE, LLC | 2 | 2 | 1 | 3 | 0 | 8 |
ROCKEFELLER UNIVERSITY | 1 | 1 | 3 | 1 | 2 | 8 |
UNIVERSITY OF WASHINGTON | 0 | 2 | 0 | 2 | 4 | 8 |
YALE UNIVERSITY | 3 | 2 | 1 | 1 | 1 | 8 |
APOGENIX GMBH | 0 | 0 | 3 | 3 | 1 | 7 |
BIOCON LIMITED | 4 | 0 | 1 | 1 | 1 | 7 |
CASE WESTERN RESERVE UNIVERSITY | 1 | 2 | 0 | 3 | 1 | 7 |
CITY OF HOPE | 0 | 1 | 1 | 3 | 2 | 7 |
DSM IP ASSETS B.V. | 1 | 1 | 2 | 3 | 0 | 7 |
DUKE UNIVERSITY | 2 | 0 | 3 | 2 | 0 | 7 |
ESBATECH, AN ALCON BIOMEDICAL RESEARCH UNIT, LLC | 1 | 0 | 3 | 2 | 1 | 7 |
IPSEN PHARMA S.A.S. | 1 | 2 | 1 | 1 | 2 | 7 |
ISIS INNOVATION LIMITED | 2 | 2 | 1 | 1 | 1 | 7 |
NATIONAL RESEARCH COUNCIL OF CANADA | 3 | 0 | 2 | 1 | 1 | 7 |
PALATIN TECHNOLOGIES, INC. | 1 | 1 | 2 | 2 | 1 | 7 |
RIKEN | 2 | 1 | 3 | 1 | 0 | 7 |
ROCHE GLYCART AG | 0 | 0 | 1 | 4 | 2 | 7 |
SALADAX BIOMEDICAL INC. | 2 | 2 | 2 | 0 | 1 | 7 |
UNIVERSITY OF ARKANSAS | 1 | 3 | 2 | 1 | 0 | 7 |
UNIVERSITY OF ROCHESTER | 1 | 2 | 2 | 1 | 1 | 7 |
ABBVIE BIOTHERAPEUTICS INC. | 0 | 0 | 3 | 2 | 1 | 6 |
AMYLIN PHARMACEUTICALS, INC. | 2 | 1 | 2 | 0 | 1 | 6 |
ARES-TRADING S.A. | 1 | 2 | 2 | 0 | 1 | 6 |
B.R.A.H.M.S GMBH | 1 | 0 | 3 | 1 | 1 | 6 |
BIOMERIEUX SA | 1 | 1 | 2 | 1 | 1 | 6 |
BRIGHAM AND WOMEN'S HOSPITAL, INC. | 3 | 1 | 2 | 0 | 0 | 6 |
CEM CORPORATION | 2 | 2 | 1 | 1 | 0 | 6 |
CENTOCOR ORTHO BIOTECH INC. | 1 | 3 | 2 | 0 | 0 | 6 |
CENTRE FOR ADDICTION AND MENTAL HEALTH | 0 | 2 | 2 | 2 | 0 | 6 |
COLUMBIA UNIVERSITY | 2 | 1 | 2 | 0 | 1 | 6 |
CRUCELL HOLLAND, B.V. | 1 | 5 | 0 | 0 | 0 | 6 |
CSL BEHRING GMBH | 1 | 0 | 1 | 3 | 1 | 6 |
CSL LIMITED | 0 | 2 | 3 | 1 | 0 | 6 |
FIVE PRIME THERAPEUTICS, INC. | 2 | 1 | 2 | 0 | 1 | 6 |
FUJIFILM CORPORATION | 1 | 1 | 3 | 0 | 1 | 6 |
FUSO PHARMACEUTICAL INDUSTRIES, LTD. | 2 | 0 | 3 | 0 | 1 | 6 |
INCYTE CORPORATION | 2 | 0 | 1 | 3 | 0 | 6 |
MILLENNIUM PHARMACEUTICALS, INC. | 2 | 1 | 0 | 2 | 1 | 6 |
NEW YORK UNIVERSITY | 1 | 1 | 1 | 1 | 2 | 6 |
NORTHWESTERN UNIVERSITY | 0 | 1 | 1 | 3 | 1 | 6 |
NOVOZYMES A/S | 1 | 2 | 1 | 2 | 0 | 6 |
PANASONIC CORPORATION | 1 | 0 | 0 | 5 | 0 | 6 |
PHILOGEN S.P.A. | 1 | 1 | 3 | 1 | 0 | 6 |
PIERRE FABRE MEDICAMENT | 1 | 1 | 1 | 3 | 0 | 6 |
STOWERS INSTITUTE FOR MEDICAL RESEARCH | 1 | 2 | 2 | 1 | 0 | 6 |
SYNERGY PHARMACEUTICALS, INC. | 0 | 1 | 3 | 1 | 1 | 6 |
THE UNIVERSITY OF TOKYO | 1 | 1 | 2 | 0 | 2 | 6 |
UNIVERSITY OF COLORADO, THE REGENTS OF | 0 | 1 | 0 | 4 | 1 | 6 |
UNIVERSITY OF MASSACHUSETTS | 2 | 2 | 1 | 0 | 1 | 6 |
AMSILK GMBH | 3 | 0 | 0 | 2 | 0 | 5 |
AVEO PHARMACEUTICALS, INC. | 0 | 0 | 4 | 1 | 0 | 5 |
AXELLIA PHARMACEUTICALS APS | 0 | 2 | 0 | 0 | 3 | 5 |
CANON KABUSHIKI KAISHA | 2 | 0 | 1 | 0 | 2 | 5 |
CHILDREN'S MEDICAL CENTER CORPORATION | 0 | 1 | 0 | 4 | 0 | 5 |
DAIICHI SANKYO COMPANY, LIMITED | 0 | 1 | 3 | 1 | 0 | 5 |
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS | 1 | 2 | 2 | 0 | 0 | 5 |
DOW AGROSCIENCES LLC | 2 | 2 | 0 | 0 | 1 | 5 |
FERRING B.V. | 0 | 0 | 1 | 2 | 2 | 5 |
FLORIDA STATE UNIVERSITY | 0 | 4 | 0 | 1 | 0 | 5 |
FUJIFILM MANUFACTURING EUROPE B.V. | 2 | 3 | 0 | 0 | 0 | 5 |
GENCIA CORPORATION | 1 | 0 | 2 | 0 | 2 | 5 |
GENERAL ELECTRIC COMPANY | 2 | 1 | 1 | 1 | 0 | 5 |
GENZYME CORPORATION | 0 | 1 | 2 | 2 | 0 | 5 |
GLAXOSMITHKLINE BIOLOGICALS S.A. | 1 | 0 | 0 | 1 | 3 | 5 |
IDEXX LABORATORIES, INC. | 0 | 3 | 2 | 0 | 0 | 5 |
INSTITUT PASTEUR | 0 | 2 | 0 | 3 | 0 | 5 |
ISP INVESTMENTS INC. | 0 | 1 | 3 | 1 | 0 | 5 |
LPATH INC. | 2 | 1 | 1 | 1 | 0 | 5 |
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V | 0 | 0 | 0 | 4 | 1 | 5 |
MEDAREX, L.L.C. | 0 | 0 | 1 | 4 | 0 | 5 |
MOCHIDA PHARMACEUTICAL CO., LTD. | 1 | 2 | 2 | 0 | 0 | 5 |
MOMENTA PHARMACEUTICALS, INC. | 1 | 1 | 0 | 3 | 0 | 5 |
MORPHOTEK, INC. | 0 | 1 | 2 | 1 | 1 | 5 |
NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY | 1 | 0 | 0 | 3 | 1 | 5 |
OCTAPHARMA AG | 1 | 1 | 1 | 1 | 1 | 5 |
ONCOMED PHARMACEUTICALS, INC. | 1 | 2 | 1 | 1 | 0 | 5 |
OSAKA UNIVERSITY | 1 | 0 | 1 | 0 | 3 | 5 |
PFIZER INC. | 1 | 2 | 1 | 1 | 0 | 5 |
SANDOZ AG | 1 | 1 | 2 | 1 | 0 | 5 |
SHANGHAI TECHWELL BIOPHARMACEUTICAL CO., LTD | 0 | 0 | 0 | 1 | 4 | 5 |
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH | 3 | 1 | 0 | 1 | 0 | 5 |
SPIBER TECHNOLOGIES AB | 0 | 2 | 1 | 2 | 0 | 5 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0 | 0 | 2 | 1 | 2 | 5 |
UAB RESEARCH FOUNDATION | 2 | 0 | 0 | 3 | 0 | 5 |
UNITED STATES OF AMERICA, NAVY | 1 | 2 | 1 | 0 | 1 | 5 |
UNIVERSITY OF IOWA RESEARCH FOUNDATION | 0 | 2 | 1 | 2 | 0 | 5 |
UNIVERSITY OF MICHIGAN | 0 | 1 | 0 | 2 | 2 | 5 |
UNIVERSITY OF TOLEDO | 1 | 1 | 0 | 2 | 1 | 5 |
UNIVERSITY OF UTAH RESEARCH FOUNDATION | 0 | 1 | 3 | 1 | 0 | 5 |
VASGENE THERAPEUTICS, INC. | 2 | 1 | 0 | 0 | 2 | 5 |
WASHINGTON UNIVERSITY | 0 | 2 | 3 | 0 | 0 | 5 |
Questions regarding these reports should be directed to:
U.S. Patent and Trademark Office
Electronic Information Products Division - PTMT
P.O Box 1450
Alexandria VA 22313-1450tel: (571) 272-5600
fax: (571) 273-0110
email: oeip@uspto.govaddress of PTMT pages at the USPTO Web Site: http://www.uspto.gov/web/offices/ac/ido/oeip/taf/reports.htm
selected PTMT files available for download at : http://www.uspto.gov/web/offices/ac/ido/oeip/taf/data/
Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports